TennesseeTennCare - As introduced, requires a managed care organization or pharmacy benefits manager that is contracted with the bureau to reimburse a claim for a long-acting injectable drug intended for treatment and prevention of human immunodeficiency virus and administered in a pharmacy, physician's office, clinic, ambulatory surgical treatment center, or hospital. - Amends TCA Title 4; Title 56 and Title 71.
What it does
Plain-language analysis is being updated.
Use the official record and source text while enrichment finishes.
Where do you stand?
Choose your position
Tell your reps
Take a position to see your representatives and ways to contact them.
Where it stands
- Introduced
- Passed House
- Passed Senate
- To Governor
- Became Law
Looking ahead
No hearings or votes scheduled.
History
- 2026
- Mar 3Taken off notice for cal in s/c Tenncare Subcommittee of Insurance CommitteeLatest
- Feb 25Placed on s/c cal Tenncare Subcommittee for 3/3/2026
- Feb 5P2C, ref. to Insurance CommitteeMinor
- Feb 5Assigned to s/c Tenncare SubcommitteeMinor
- Feb 4Intro., P1C.Minor
- Feb 4Sponsor change.Minor
- Feb 3Filed for introductionIntroduced